Literatura

1. ^Chackalamannil S; Davies RJ; Wang Y; et al. (1999). „Total Synthesis of (+)-Himbacine and (+)-Himbeline”.J. Org. Chem.64 (6): 1932—1940.PMID 11674285.doi:10.1021/jo981983. CS1 одржавање: Експлицитна употреба et al. (веза)
2. ^Malaska MJ, Fauq AH, Kozikowski AP, Aagaard PJ, McKinney M (1995). „Chemical Modification of Ring C of Himbacine: Discovery of a Pharmacophoric Element for M2-Selectivity”.Bioorganic and Medicinal Chemistry Letters.5 (1): 61—66.doi:10.1016/0960-894X(94)00459-S. 
3. ^Chackalamannil S, Doller D, McQuade R, Ruperto V (2004). „Himbacine analogs as muscarinic receptor antagonists-effects of tether and heterocyclic variations”.Bioorganic and Medicinal Chemistry Letters.14 (15): 3967—3970.PMID 15225708.doi:10.1016/j.bmcl.2004.05.047. 
4. ^Chackalamannil S; Wang Y; Greenlee WJ; et al. (2008). „Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity”.J. Med. Chem.51 (11): 3061—3064.PMID 18447380.doi:10.1021/jm800180e. CS1 одржавање: Експлицитна употреба et al. (веза)
5. ^„Blog entry about Himbacine and its history in drug development”. Архивирано изоригинала 19. 01. 2011. г. 

Spoljašnje veze